Showing results (971-980 of 7,009) with videos related to

Sort By:
Pageof 701
Lung Cancer (Amsterdam, Netherlands)|August 31, 2015
Validation of survival prognostic models for non-small-cell lung cancer in stage- and age-specific groupsXiaofei Wang, Lin Gu, Ying Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|October 12, 2015
Take-home message in times of crisis: Is it really better to treat with cisplatin & pemetrexed than cisplatin & gemcitabine in first line NSCLC? The power of statistical considerationsChristian Rolfo, Eduardo Castañon
Lung Cancer (Amsterdam, Netherlands)|July 10, 2016
Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancerTony Mok, Guia Ladrera, Vichien Srimuninnimit, et al.
Lung Cancer (Amsterdam, Netherlands)|July 10, 2016
Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancerFumihiro Shoji, Yosuke Morodomi, Takaki Akamine, et al.
Lung Cancer (Amsterdam, Netherlands)|July 10, 2016
Air bronchogram: A potential indicator of epidermal growth factor receptor mutation in pulmonary subsolid nodulesJie Dai, Jingyun Shi, Adiilah K Soodeen-Lalloo, et al.
Lung Cancer (Amsterdam, Netherlands)|July 10, 2016
Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American populationKrista A Zanetti, Zhaoming Wang, Melinda Aldrich, et al.
Lung Cancer (Amsterdam, Netherlands)|July 10, 2016
Clinical and pathologic features of lung cancer expressing programmed cell death ligand 1 (PD-L1)Masaki Shimoji, Shigeki Shimizu, Katsuaki Sato, et al.
Lung Cancer (Amsterdam, Netherlands)|July 10, 2016
Advanced non-Small cell lung cancer patients at the extremes of age in the era of epidermal growth factor receptor tyrosine kinase inhibitorsYu-Mu Chen, Chien-Hao Lai, Kun-Ming Rau, et al.
Lung Cancer (Amsterdam, Netherlands)|June 28, 2016
Precision medicine in age-specific non-small-cell-lung-cancer patients: Integrating biomolecular results into clinical practice-A new approach to improve personalized translational researchTiziana Vavalà, Valentina Monica, Marco Lo Iacono, et al.
Lung Cancer (Amsterdam, Netherlands)|September 21, 2015
Genetic polymorphism in the epidermal growth factor receptor gene predicts outcome in advanced non-small cell lung cancer patients treated with erlotinibAnne Winther-Larsen, Peter Henrik Nissen, Kristine Raaby Jakobsen, et al.
Pageof 701